Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Illinois Tool Works Wynn Resorts Agree Realty Crispr Therapeutics Super Micro Computer: Trending by Analysts

May 15, 2025
Illinois Tool Works Inc. (NYSE: ITW) has been gaining attention from analysts recently, along with other companies such as Wynn Resorts, Agree Realty, Crispr Therapeutics, and Super Micro Computer. With a 3.6% increase in stock price on May 12, ITW is showing strong growth potential. Investors should keep an eye on these companies as they continue to trend upward according to analysts. For more detailed insight on the movement of ITW stock, we recommend consulting with professionals from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for ITW

Related data

ITWApril 8, 2025QuantWave Achieves 6.13% Profit Target Forecast for Illinois Tool Works Inc.  ~1 min.

On June 11, 2024, QuantWave, an automated forecasting platform, issued a short signal for Illinois Tool Works Inc. (ITW) with a price target of $218.41. The stock was trading at $232....

ITWApril 8, 2025ILLINOIS TOOL WORKS INC. Stock Hits Price Target, Yielding 5.8% Profit as Forecasted by QuantWave  ~1 min.

On May 28, 2024, QuantWave's automated forecasting platform provided a short signal for ILLINOIS TOOL WORKS INC. stock when it was trading at 231.87 $....

ITWApril 8, 2025QuantWave Achieves Profitable Forecast with Illinois Tool Works Inc., Generating 6.02% Return  ~1 min.

Illinois Tool Works Inc. (ITW) investors are celebrating as QuantWave's forecast signal for the stock hit the mark, yielding a profitable 6.02% return....

ITWApril 8, 2025QuantWave Achieves 7.08% Profit Target with Illinois Tool Works Inc. Stock Forecast  ~1 min.

QuantWave, the automated forecasting platform, successfully hit a profit target of 7.08% with its short direction prediction for Illinois Tool Works Inc. (ITW) stock....

ITWApril 8, 2025ILLINOIS TOOL WORKS INC. Hits QuantWave Price Target Forecast with 5.6% Profit  ~1 min.

ILLINOIS TOOL WORKS INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 5.6% for investors....

ITWApril 8, 2025QuantWave Hits Forecast of Short Direction for Illinois Tool Works Inc. with 7.01% Profit  ~1 min.

Illinois Tool Works Inc. has achieved the price target forecast set by QuantWave, hitting a profit of 7.01% after moving in a short direction....

ITWApril 8, 2025ILLINOIS TOOL WORKS INC. Price Target Forecast Achieved with 6.02% Profit  ~1 min.

QuantWave, a leading automated forecasting platform, successfully predicted the price movement of ILLINOIS TOOL WORKS INC. stock....

ITWApril 7, 2025ILLINOIS TOOL WORKS INC. Hits QuantWave Forecast Price Target with 5.47% Profit  ~2 min.

ILLINOIS TOOL WORKS INC. (ITW) recently reached the price target forecasted by QuantWave, resulting in a profit of 5.47% for investors....

ITWApril 7, 2025ILLINOIS TOOL WORKS INC. Hits Price Target Forecast with 5.31% Profit  ~1 min.

ILLINOIS TOOL WORKS INC. has successfully reached the price target forecast predicted by QuantWave on April 7, 2025. The forecast signal was initiated on August 6, 2024, with the stock priced at 234....

ITWApril 4, 2025QuantWave Hits Bullseye with 8.7% Profit on Illinois Tool Works Inc. Forecast  ~2 min.

QuantWave, the automated forecasting platform, has once again showcased its accuracy with a successful prediction on the stock of Illinois Tool Works Inc. (ITW)....

ABBVDecember 18, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics in a Game-Changing Move  ~1 min.

AbbVie Inc., a leading biopharmaceutical company, has announced its acquisition of Nimble Therapeutics, a pioneer in the field of immunology....

AZNOctober 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment  ~1 min.

Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....

ABBVJanuary 29, 2025AbbVie Inc. Completes Acquisition of Nimble Therapeutics  ~2 min.

AbbVie Inc., a global biopharmaceutical company, has successfully completed its acquisition of Nimble Therapeutics, a biotherapeutics discovery company....

BIIBJanuary 12, 2025Sage Therapeutics Receives Surprise Acquisition Offer from Biogen  ~2 min.

Biogen Inc., a leading biotechnology company, has made a surprise acquisition offer to Sage Therapeutics, a company specializing in the development of therapies for central nervous system disorders....

ABBVDecember 20, 2024AbbVie ABBV to Acquire Nimble Therapeutics Further Strengthening Immunology Pipeline  ~1 min.

AbbVie Inc. (NYSE: ABBV) has announced its plans to acquire Nimble Therapeutics, a biotechnology company specializing in antibody drug discovery....